Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can video therapy help kids with cerebral palsy move better?

NCT ID NCT06486987

Symptom relief Sponsor: Warren Lo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether constraint-induced movement therapy (CIMT) can be effectively delivered via video in the homes of 10 children aged 4-10 with hemiplegic cerebral palsy. The therapy involves encouraging use of the weaker arm while restraining the stronger one. Researchers will measure arm function before and after treatment to estimate how well this remote approach works, aiming to inform a larger future study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Constraint-induced movement therapy delivered by televideo
What this could lead to
If it works, this could provide a convenient home-based therapy option to improve arm function in children with hemiplegic cerebral palsy.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply to all children. The therapy is delivered remotely, which may affect how well it works compared to in-person sessions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 10 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children who have hemiplegic cerebral palsy, ages 4-10; * hemiparesis ranging from Manual Ability Classification System (MACS) I to MACS IV; * live within a 1.5 hour distance from therapists' worksites at the Ohio State University Wexner Medical Center in Columbus, Ohio, or the Fralin Biomedical Research Institute in Roanoke, Virginia; * are willing to travel to these sites for two in-person assessments. Exclusion Criteria: * Previous high dose CIMT (defined as CIMT given 2 hrs per day for 10 days) in the 6 months preceding baseline assessment; * Treatment with botulinum toxin for spasticity in the 3 months preceding baseline assessment; * Surgery for spasticity in the 6 months preceding baseline assessment; * Medically unstable and unable to participate in the treatment intervention; * Child is behaviorally or cognitively impaired so unable to participate in the treatment intervention; * Family unable to participate in tele-delivery of CIMT 5 days a week for 4 weeks; * the caregiver available at child's treatment site during treatment times is unable to communicate with the treating therapist.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiplegic cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy spastic hemiplegic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemiplegic cerebral palsy

Contacts and locations

Locations

  • The Ohio State University School of Health and Rehabilitation Sciences

    Columbus, Ohio, 43210, United States

  • Virginia Tech-Fralin Biomedical Research Institute

    Roanoke, Virginia, 24016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.